Download PDF
Thromb Haemost 2009; 102(06): 1080-1092
DOI: 10.1160/TH09-07-0499
Theme Issue Article
Schattauer GmbH

Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli

Martina Bielaszewska   *
1   Institute of Hygiene, University of Münster, Münster, Germany
,
Andreas Bauwens   *
1   Institute of Hygiene, University of Münster, Münster, Germany
,
Lilo Greune
2   Institute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
,
Björn Kemper
3   Center for Biomedical Optics and Photonics, University of Münster, Münster, Germany
,
Ulrich Dobrindt
4   Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany
,
Joyce M. Geelen
5   Department of Pediatric Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
,
Kwang S. Kim
6   Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
,
M. Alexander Schmidt
2   Institute of Infectiology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany
,
Helge Karch
1   Institute of Hygiene, University of Münster, Münster, Germany
› Author AffiliationsFinancial support: This study was supported by the Deutsche Forschungsgemeinschaft (DFG) program “Infections of the endothelium” SPP 1130 (grant no. KA 717/4–2), by a grant from the DFG-funded International Graduate School “Molecular interactions of pathogens with biotic and abiotic surfaces” (GRK1409), by the DFG Collaborative Research Centers SFB293 (Project B5) and SFB479 (Project A1), by the ERA-NET PathoGenoMics (grants no. PTJ-BIO/0313937A and PTJ-BIO/0313937C), by the German Competence Network PathoGenoMik (PTJ-BIO/03U213BVBIIIPG3), and by the German Federal Ministry for Education and Research (BMBF) research program “Biophotonics”.
Further Information

Publication History

Received: 10 July 2009

Accepted after major revision: 06 October 2009

Publication Date:
28 November 2017 (online)

Also available at
    Permissions and Reprints

Summary

Enterohaemorrhagic Escherichia coli (EHEC) cause haemolytic uraemic syndrome (HUS),a thrombotic microangiopathy resulting from endothelial injury in the renal glomeruli and other organs. EHEC virulence factors that damage the microvascular endothelium play therefore major roles in the pathogenesis of HUS.We identified an EHEC strain that vacuolates and kills primary human glomerular microvascular endothelial cells (GMVECs) and a human brain microvascular endothelial cell (HBMEC) line. Because the vacuolating effect closely resembles those elicited on other cells by the vacuolating cytotoxin of Helicobacter pylori (VacA), we designated the factor responsible for this effect EHEC vacuolating cytotoxin (EHEC-Vac). EHEC-Vac (a secreted non-serine protease protein) binds to HBMECs rapidly and irreversibly, vacuolates within 30 min after exposure and the effect is maximally apparent at 48 h. Despite the vacuolisation, HBMECs survive for several days before they undergo necrosis. Electron and immunofluorescence microscopy demonstrate that the vacuoles induced by EHEC-Vac originate from lysosomes.Accordingly, they stain with neutral red indicating an acidic microenvironment. Similar to VacA, the EHEC-Vac-mediated vacuolisation is both prevented and reverted by the vacuolar proton pump inhibitor bafilomycin A1, suggesting a similar mechanism of vacuole formation by these toxins. Despite the similarity of phenotypes elicited by EHEC-Vac and VacA, genomic DNA from the EHEC-Vac-producing strain failed to hybridise to a vacA probe, as well as to probes derived from presently known E. coli vacuolating toxins.Through its microvascular endothelium-injuring potential combined with the ability to induce interleukin 6 release from these cells EHEC-Vac might contribute to the pathogenesis of HUS.

Keywords

Enterohaemorrhagic E. coli - haemolytic uraemic syndrome - vacuolating cytotoxin - EHEC-Vac - microvascular endothelial injury

* Both authors contributed equally to this study.


 

  • References

  • 1 Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 2005; 295: 405-418.
    CrossrefPubMedGoogle Scholar
  • 2 Tarr PI, Gordon CA, Chandler WL. Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-1086.
    PubMedGoogle Scholar
  • 3 Andreoli SP, Trachtman H, Acheson DWK. et al. Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 2002; 17: 293-298.
    CrossrefPubMedGoogle Scholar
  • 4 Richardson SE, Karmali MA, Becker LE. et al. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988; 19: 1102-1108.
    CrossrefPubMedGoogle Scholar
  • 5 Upadhyaya K, Barwick K, Fishaut M. et al. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 1980; 65: 115-120.
    PubMedGoogle Scholar
  • 6 Bielaszewska M, Karch H. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb Haemost 2005; 94: 312-318.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Dehio C. Bartonella interactions with endothelial cells and erythrocytes. Trends Microbiol 2001; 09: 279-285.
    CrossrefPubMedGoogle Scholar
  • 8 Sandvig K. Shiga toxins. Toxicon 2001; 39: 1629-1635.
    CrossrefPubMedGoogle Scholar
  • 9 Müthing J, Schweppe CH, Karch H. et al. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost 2009; 101: 252-264.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Janka A, Bielaszewska M, Dobrindt U. et al. Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H− and O157:H7: characterization and evolutionary considerations. Infect Immun 2003; 71: 3634-3638.
    CrossrefPubMedGoogle Scholar
  • 11 Friedrich AW, Lu S, Bielaszewska M. et al. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J Clin Microbiol 2006; 44: 1844-1846.
    CrossrefPubMedGoogle Scholar
  • 12 Bielaszewska M, Fell M, Greune L. et al. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun 2004; 72: 1812-1816.
    CrossrefPubMedGoogle Scholar
  • 13 Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 1995; 63: 1055-1061.
    PubMedGoogle Scholar
  • 14 Bielaszewska M, Sinha B, Kuczius T. et al. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation and death of human endothelial cells. Infect Immun 2005; 73: 552-562.
    CrossrefPubMedGoogle Scholar
  • 15 Schmidt H, Maier E, Karch H. et al. Pore-forming properties of the plasmid-encoded hemolysin of enterohemorrhagic Escherichia coli O157:H7. Eur J Biochem 1996; 241: 594-601.
    CrossrefPubMedGoogle Scholar
  • 16 Aldick T, Bielaszewska M, Zhang W. et al. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. Microbes Infect 2007; 09: 282-290.
    CrossrefPubMedGoogle Scholar
  • 17 Paton AW, Srimanote P, Talbot UM. et al. A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli . J Exp Med 2004; 200: 35-46.
    CrossrefPubMedGoogle Scholar
  • 18 Leunk RD, Johnson PT, David BC. et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori . J Med Microbiol 1988; 26: 93-99.
    CrossrefPubMedGoogle Scholar
  • 19 Zhang W, Bielaszewska M, Friedrich AW. et al. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli . Appl Environ Microbiol 2005; 71: 558-561.
    CrossrefPubMedGoogle Scholar
  • 20 Brzuszkiewicz E, Bruggemann H, Liesegang H. et al. How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 2006; 103: 12879-12884.
    CrossrefPubMedGoogle Scholar
  • 21 Welch RA, Burland V, Plunkett III G. et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli . Natl Acad Sci USA 2002; 99: 17020-17024.
    CrossrefPubMedGoogle Scholar
  • 22 Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 1997; 76: 81-90.
    CrossrefPubMedGoogle Scholar
  • 23 van Setten PA, van Hinsbergh VWM, van der Velden TJAN. et al. Effects of TNF on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997; 51: 1245-1256.
    CrossrefPubMedGoogle Scholar
  • 24 Cover TL, Reddy LY, Blaser MJ. Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin. Infect Immun 1993; 61: 1427-1431.
    PubMedGoogle Scholar
  • 25 Coelho A, Andrade JR, Vicente AC. et al. Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin. Infect Immun 2000; 68: 1700-1705.
    CrossrefPubMedGoogle Scholar
  • 26 Figueroa-Arredondo P, Heuser JE, Akopyants NS. et al. Cell vacuolation caused by Vibrio cholerae hemolysin. Infect Immun 2001; 69: 1613-1624.
    CrossrefPubMedGoogle Scholar
  • 27 Kügler S, Böcker K, Heusipp G. et al. Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model. Cell Microbiol 2007; 09: 619-632.
    CrossrefPubMedGoogle Scholar
  • 28 Nicoletti I, Migliorati G, Pagliacci MC. et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide and flow cytometry. J Immunol Methods 1991; 139: 271-279.
    CrossrefPubMedGoogle Scholar
  • 29 Kemper B, Carl D, Höink A. et al. Modular digital holographic microscopy system for marker-free quantitative phase contrast imaging of living cells. Proc SPIE 2006; 6191: 61910T.1-61910T.8.
    PubMedGoogle Scholar
  • 30 Kemper B, Carl D, Schnekenburger J. et al. Investigation of living pancreas tumor cells by digital holographic microscopy. J Biomed Opt 2006; 11: 34005.
    CrossrefPubMedGoogle Scholar
  • 31 Tomb JF, White O, Kerlavage AR. et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. . Nature 1997; 388: 539-547.
    CrossrefPubMedGoogle Scholar
  • 32 Parreira VR, Gyles CL. A novel pathogenicity island integrated adjacent to the thrW tRNA gene of avian pathogenic Escherichia coli encodes a vacuolating autotransporter toxin. Infect Immun 2003; 71: 5087-5096.
    CrossrefPubMedGoogle Scholar
  • 33 Guyer DM, Henderson IR, Nataro JP. et al. Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli . Mol Microbiol 2000; 38: 53-66.
    CrossrefPubMedGoogle Scholar
  • 34 Ewers C, Janssen T, Kiessling S. et al. Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. Vet Microbiol 2004; 104: 91-101.
    CrossrefPubMedGoogle Scholar
  • 35 Cover TL, Puryear W, Perez-Perez GI. et al. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun 1991; 59: 1264-70.
    PubMedGoogle Scholar
  • 36 Bowman EJ, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from micro-organisms, animal cells, and plant cells. Proc Natl Acad Sci USA 1988; 85: 7972-7976.
    CrossrefPubMedGoogle Scholar
  • 37 Papini E, Bugnoli M, De Bernard M. et al. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol 1993; 07: 323-327.
    CrossrefPubMedGoogle Scholar
  • 38 Szabò I, Brutsche S, Tombola F. et al. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 1999; 18: 5517-5527.
    CrossrefPubMedGoogle Scholar
  • 39 Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005; 03: 320-332.
    CrossrefPubMedGoogle Scholar
  • 40 Holtzman E. Lysosomes. Springer Verlag; 2007.
  • 41 Salvadori MR, Yano T, Carvalho HE. et al. Vacuolating cytotoxin produced by avian pathogenic Escherichia coli . Avian Dis 2001; 45: 43-51.
    CrossrefPubMedGoogle Scholar
  • 42 Guyer DM, Radulovic S, Jones FE. et al. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 2002; 70: 4539-4546.
    CrossrefPubMedGoogle Scholar
  • 43 Mitra R, Figueroa P, Mukhopadhyay AK. et al. Cell vacuolation a manifestation of the El Tor hemolysin of Vibrio cholerae . Infect. Immun 2000; 68: 1928-1933.
    CrossrefPubMedGoogle Scholar
  • 44 Hertle R, Hilger M, Weingardt-Kocher S. et al. Cytotoxic action of Serratia marcescens hemolysin on human epithelial cells. Infect Immun 1999; 67: 817-825.
    PubMedGoogle Scholar
  • 45 Abrami L, Fivaz M, Glauser PE. et al. A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. J Cell Biol 1998; 140: 525-540.
    CrossrefPubMedGoogle Scholar
  • 46 Morinaga N, Yahiro K, Matsuura G. et al. Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli . Infect Immun 2007; 75: 488-496.
    CrossrefPubMedGoogle Scholar
  • 47 Papini E, de Bernard M, Milia E. et al. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci USA 1994; 91: 9720-9724.
    CrossrefPubMedGoogle Scholar
  • 48 Molinari M, Galli C, Norais N. et al. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J Biol Chem 1997; 272: 25339-25344.
    CrossrefPubMedGoogle Scholar
  • 49 Reading NC, Torres AG, Kendall MM. et al. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J Bacteriol 2007; 189: 2468-2476.
    CrossrefPubMedGoogle Scholar
  • 50 Guimarães MS, Andrade JR, Freitas-Almeida AC. et al. Aeromonas hydrophila vacuolating activity in the Caco-2 human enterocyte cell line as a putative virulence factor. FEMS Microbiol Lett 2002; 207: 127-131.
    CrossrefPubMedGoogle Scholar
  • 51 Kang G, Pulimood AB, Koshi R. et al. A monkey model for enterohemorrhagic Escherichia coli infection. J Infect Dis 2001; 184: 206-210.
    CrossrefPubMedGoogle Scholar